Amgen Wins Legal Round: Amgen Inc. said...
From Times Staff and Wire Reports
Amgen Wins Legal Round: Amgen Inc. said a federal appeals court agreed to temporarily stay a lower court order that called for the Thousand Oaks biotechnology company and Genetics Institute, its rival, to share the market for a lucrative anti-anemia drug called erythropoietin, or EPO. A federal judge in Boston last month ordered Amgen to present a plan by today for the companies to share the market. But Amgen appealed that order, and the deadline was subsequently postponed by the appellate court action.
